UnitedHealth (UNH) reported Q2 FY 2019 earnings of $3.60 per share (versus $3.14 in Q2 FY 2018), beating analysts’ consensus of $3.46.
The company’s quarterly revenues amounted to $60.595 bln (+8.0% y/y), generally in line with analysts’ consensus estimate of $60.587 bln.
The company raised FY19 EPS guidance to $14.70-14.90 from prior $14.50-14.75 versus analysts’ consensus estimate of $14.71.
UNH rose to $268.68 (+0.76%) in pre-market trading.